MorphoSys AG: Announcement of the Convening of the General Meeting in Munich/Germany on 31/5/2012 according to §121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
(Thomson Reuters ONE) -
MorphoSys AG /
MorphoSys AG: Announcement of the Convening of the General Meeting in
Munich/Germany on 31/5/2012 according to §121 AktG (German Stock Companies Act)
with the objective of Europe-wide distribution
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
MorphoSys AG
Martinsried/Planegg
Securities' code numbers: 663200 and A1MBF5
ISIN: DE0006632003 and DE000A1MBF50
Reading and Convenience Translation
Invitation to the Annual Shareholders' Meeting 2012
We hereby invite the shareholders of our Company to the Annual Shareholders'
Meeting which is taking place on May 31, 2012 at 10:00 a.m., in the Conference
Centre Munich, Hanns-Seidel-Stiftung, Lazarettstraße 33, 80636 Munich.
Agenda
1. Presentation of the confirmed annual financial statements as of December
31, 2011, the management report together with the consolidated financial
statements, the consolidated management report and the report of the
Supervisory Board for the business year 2011 and the statement of the Board
of Management to the items pursuant to § § 289 para. 4, 315 para. 4 HGB
2. Resolution on the use of the net earnings of MorphoSys AG
Resolution on the formal approval on behalf of the Board of Management
3. Resolution on the formal approval on behalf of the Supervisory Board
4. Resolution on the appointment of the auditors for the business year 2012
5. Resolution on the new election of supervisory board members
6. Resolution on the deletion of the Authorized Capital 2008-I and creation of
a new Authorized Capital 2012-I with the possibility to exclude pre-emptive
rights of the shareholders; amendment of the Articles
7. Resolution on the deletion of the Authorized Capital 2008-II and creation of
a new Authorized Capital 2012-II with the possibility to exclude pre-emptive
rights of the shareholders; amendment of the Articles
8. Resolution on the compensation of the Supervisory Board
Please find the full text of the announcement here: www.morphosys.com/agm
About MorphoSys:
MorphoSys developed HuCAL, the most successful antibody library technology in
the pharmaceutical industry. By successfully applying this and other patented
technologies, MorphoSys has become a leader in the field of therapeutic
antibodies, one of the fastest-growing drug classes in human healthcare. The
company's AbD Serotec unit uses HuCAL and other antibody technologies to
generate superior monoclonal antibodies for research and diagnostic
applications.
Together with its pharmaceutical partners, MorphoSys has built a therapeutic
pipeline of more than 70 human antibody drug candidates for the treatment of
cancer, rheumatoid arthritis, and Alzheimer's disease, to name just a few. With
its ongoing commitment to new antibody technology and drug development,
MorphoSys is focused on making the healthcare products of tomorrow. MorphoSys is
listed on the Frankfurt Stock Exchange under the symbol MOR. For regular updates
about MorphoSys, visit http://www.morphosys.com
For more information, please contact:
MorphoSys AG
Dr. Claudia Gutjahr-Löser
Head of Corporate Communications & IR
Tel: +49 (0) 89 / 899 27-122
Mario Brkulj
Senior Manager Corporate Communications & IR
Tel: +49 (0) 89 / 899 27-454
Jessica Kulpi
Specialist Corporate Communications & IR
Tel: +49 (0) 89 / 899 27-332
investors(at)morphosys.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: MorphoSys AG via Thomson Reuters ONE
[HUG#1603374]
Unternehmensinformation / Kurzprofil:
Datum: 18.04.2012 - 07:31 Uhr
Sprache: Deutsch
News-ID 136203
Anzahl Zeichen: 4476
contact information:
Town:
Martinsried / München
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 275 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"MorphoSys AG: Announcement of the Convening of the General Meeting in Munich/Germany on 31/5/2012 according to §121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution"
steht unter der journalistisch-redaktionellen Verantwortung von
MorphoSys AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
